SARS-Like coronavirus WIV1-CoV does not replicate in Egyptian fruit bats (Rousettus aegyptiacus)

  • Neeltje van Doremalen
  • , Alexandra Schäfer
  • , Vineet D. Menachery
  • , Michael Letko
  • , Trenton Bushmaker
  • , Robert J. Fischer
  • , Dania M. Figueroa
  • , Patrick W. Hanley
  • , Greg Saturday
  • , Ralph S. Baric
  • , Vincent J. Munster

Research output: Contribution to journalArticlepeer-review

Abstract

Severe acute respiratory syndrome (SARS)-like WIV1-coronavirus (CoV) was first isolated from Rhinolophus sinicus bats and can use the human angiotensin converting enzyme 2 (ACE2) receptor. In the current study, we investigate the ability of WIV1-CoV to infect Rousettus aegyptiacus bats. No clinical signs were observed throughout the experiment. Furthermore, only four oropharyngeal swabs and two respiratory tissues, isolated on day 3 post inoculation, were found positive for viral RNA. Two out of twelve bats showed a modest increase in coronavirus specific antibodies post challenge. In conclusion, WIV1-CoV was unable to cause a robust infection in Rousettus aegyptiacus bats.

Original languageEnglish (US)
Article number727
JournalViruses
Volume10
Issue number12
DOIs
StatePublished - Dec 2018
Externally publishedYes

Keywords

  • Animal model
  • Coronavirus
  • Emerging infectious diseases
  • WIV1-CoV

ASJC Scopus subject areas

  • Infectious Diseases
  • Virology

Fingerprint

Dive into the research topics of 'SARS-Like coronavirus WIV1-CoV does not replicate in Egyptian fruit bats (Rousettus aegyptiacus)'. Together they form a unique fingerprint.

Cite this